Funder
National Institute for Innovation in Manufacturing Biopharmaceuticals
Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases
Reference73 articles.
1. Chimeric antigen receptor modified T cells: CD19 and the road beyond;Salter;Blood,2018
2. Adoptive T cell therapy: points to consider;Yee;Curr Opin Immunol,2018
3. Cellular therapies: day by day, all the way;Atilla;Transfus Apher Sci,2018
4. The retroviral vector family: something for everyone;Elsner;Virus Genes,2017
5. Clinical protocol. A phase 1 open-label clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects;MacGregor;Hum Gene Ther,2001
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献